Position: Client Support Specialist Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for …
At Biomedix, we strive to promote top-notch vascular care and have compiled the reimbursement rates for PADnet tests, including CPT codes 93922, 93923, and 93924, as well as office visit E/M codes, for the year 2023. Market-by-market data has been …
FDA Clearance For PADnet Xpress For Home Use Twin Cities, MN— November 30th, 2022 — Biomedix, a market-leading medical technology and innovation company, announced that the PADnet Xpress device has received clearance from the FDA for use in the home. “We are …
Living with peripheral artery disease (PAD) can be challenging enough, but for people experiencing food insecurity, the risks of heart disease and other cardiovascular conditions can be significantly higher. According to a recent study presented at the American Heart Association’s …
New integration option aggregating bi-directional interfacing between multiple devices across multiple modalities. Twin Cities, MN — October 6th, 2022 Biomedix announced the availability of a bi-directional interface designed to support the automated integration between their Biomedix Xchange point-of-care diagnostic platform, …
A new study found that walking at a pace that induces pain or discomfort is better at improving walking availability for people with Peripheral Artery Disease (PAD). The study covered 264 people with PAD, with participants from four U.S medical centers. Designed …
A recent retrospective cohort study of Medicare patients hospitalized with a diabetic foot ulcer found an intersectionality of patients who identify as black as well as rural patients, and the mortality probability or probability of major leg amputation. This study …
The Centers for Medicare & Medicaid Services recently published their final rule for Medicare Advantage plans for 2023. One of the new initiatives reflected in these rules is an effort to increase equity and access to affordable care, an effort …
A study recently published in the Journal of the American Podiatric Medical Association examined the combined utility of a timed vibration test (TVT) combined with monofilament, and compared the effectiveness of using these technologies separately to predict diabetic foot ulcers …
Stop by booth 308 to check out PADnet Xpress, the world’s best cuff-free vascular disease diagnostic technology. Make sure to stop by our roundtable 8-9am on Wednesday, March 9th, titled: Boosting HCC capture and gap closure during clinical encounters with …